1. Home
  2. CSWC vs ATRC Comparison

CSWC vs ATRC Comparison

Compare CSWC & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capital Southwest Corporation

CSWC

Capital Southwest Corporation

HOLD

Current Price

$25.47

Market Cap

1.6B

ML Signal

HOLD

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$48.56

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSWC
ATRC
Founded
1961
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
CSWC
ATRC
Price
$25.47
$48.56
Analyst Decision
Buy
Strong Buy
Analyst Count
5
7
Target Price
$23.50
$51.17
AVG Volume (30 Days)
588.2K
731.6K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
10.89%
N/A
EPS Growth
29.25
74.74
EPS
0.39
0.18
Revenue
$10,835,000.00
$201,630,000.00
Revenue This Year
$17.45
$15.27
Revenue Next Year
$10.26
$12.21
P/E Ratio
$65.13
$273.72
Revenue Growth
16.08
15.40
52 Week Low
$19.37
$25.36
52 Week High
$25.48
$49.88

Technical Indicators

Market Signals
Indicator
CSWC
ATRC
Relative Strength Index (RSI) 70.24 77.36
Support Level $22.76 $26.47
Resistance Level N/A N/A
Average True Range (ATR) 0.27 1.64
MACD 0.04 0.09
Stochastic Oscillator 99.58 89.80

Price Performance

Historical Comparison
CSWC
ATRC

About CSWC Capital Southwest Corporation

Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source of revenue comprises interest income and dividend income from investments made as well as management fees.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: